ST高升(000971) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥187,568,549.04, a decrease of 2.08% compared to the same period last year[3] - The net profit attributable to shareholders was -¥42,337,649.77, representing a significant decline of 659.30% year-on-year[3] - The net profit after deducting non-recurring gains and losses was -¥50,637,398.52, a decrease of 790.37% compared to the previous year[3] - Total operating revenue for Q3 2021 was CNY 543,738,381.70, a decrease of 8.3% from CNY 593,069,825.06 in the same period last year[21] - Net profit for Q3 2021 was a loss of CNY 85,187,884.05, compared to a profit of CNY 26,616,335.71 in Q3 2020[22] - The company's weighted average return on equity was -3.86%, a decline of 4.57% year-on-year[3] - The company reported a basic and diluted earnings per share of -0.08, compared to 0.026 in the same period last year[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,098,611,482.50, reflecting a slight increase of 0.59% from the end of the previous year[3] - The company's total assets amounted to CNY 2,098,611,482.50, an increase from CNY 2,086,308,725.51 at the end of the previous quarter[19] - Total liabilities were CNY 926,157,212.36, slightly up from CNY 923,115,670.32 in the previous quarter[19] - The company reported a total asset value of 2,086,308,725.51 CNY, with a total liability of 1,107,474,238.14 CNY, indicating a healthy asset-to-liability ratio[30] - The company’s total liabilities increased by 68,497,110.36 CNY compared to the previous year, reflecting changes in financial obligations[30] - Current liabilities totaled ¥466,577,070.85, with a significant portion in other payables amounting to ¥199,101,778.16[31] - Non-current liabilities were recorded at ¥456,538,599.47, reflecting a decrease of ¥53,352,588.46[31] Cash Flow - The cash flow from operating activities showed a net outflow of -¥80,444,697.67, a decrease of 5.62% year-to-date[3] - The company's cash flow from operating activities was CNY 505,915,210.35, down from CNY 518,931,261.71 in the same period last year[25] - The net cash flow from operating activities was -80,444,697.67 CNY, compared to -76,162,117.52 CNY in the previous year, indicating a decline in operational cash flow[26] - The net cash flow from investment activities was -¥58,019,031.38, an increase in outflow of 59,766,210.97 compared to the same period last year[8] - The net cash flow from financing activities was -11,112,483.09 CNY, with cash inflow from borrowings amounting to 5,000,000.00 CNY[27] Inventory and Prepayments - The company reported a significant increase in inventory, which rose by 60.93% to ¥174,425,925.52, primarily due to unfinished contracts in design services[7] - The company experienced a 40.34% increase in prepayments, totaling ¥160,999,220.18, attributed to advance payments to suppliers[7] - Inventory rose significantly from CNY 108,384,713.22 at the end of 2020 to CNY 174,425,925.52 by September 30, 2021, marking an increase of approximately 61.0%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,678[10] - The largest shareholder, Tianjin Bai Ruoke Pharmaceutical Biotechnology Co., Ltd., holds 15.12% of shares, totaling 158,550,396 shares, with 109,275,198 shares pledged[10] Legal and Regulatory Matters - The company has ongoing legal matters related to unauthorized guarantees amounting to approximately CNY 839,638,400[12] - The company has not conducted an audit for the third quarter report[34] - The implementation of the new leasing standards has been adopted since January 1, 2021, affecting the accounting treatment of leases[33] - The company has not made any adjustments to prior period comparative data under the new leasing standards[34] Other Financial Metrics - The company recorded non-operating income of ¥9,205,307.87, a substantial increase compared to the previous year, mainly due to delayed compensation from a subsidiary[8] - Research and development expenses for Q3 2021 were CNY 26,778,678.17, a decrease from CNY 28,542,981.29 in the previous year[21] - The company adjusted its financial statements due to the first-time implementation of new leasing standards, affecting the balance sheet items[28] - The company's cash and cash equivalents decreased from CNY 272,845,619.12 at the end of 2020 to CNY 123,028,523.47 by September 30, 2021, representing a decline of approximately 54.8%[17] - The company’s fixed assets decreased from CNY 321,133,809.68 at the end of 2020 to CNY 265,948,570.08 by September 30, 2021, a decline of approximately 17.2%[17] - The deferred tax assets increased slightly to CNY 9,776,537.65 from CNY 9,648,482.05 in the previous quarter[18] - The total equity attributable to shareholders of the parent company was CNY 1,170,144,504.72, an increase from CNY 1,159,915,669.80 in the previous quarter[19] - The company reported a net loss of ¥2,974,632,408.01 in retained earnings[32]